Who makes Shenqu Xiaoshi oral liquid?

Shenqu Xiaoshi oral liquid is developed by Ruijin Hospital.

What development phase is Shenqu Xiaoshi oral liquid in?

Shenqu Xiaoshi oral liquid is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Shenqu Xiaoshi oral liquid

Ruijin Hospital · FDA-approved active Small molecule Quality 3/100

At a glance

Generic name	Shenqu Xiaoshi oral liquid
Also known as	SXOL
Sponsor	Ruijin Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Influence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional Dyspepsia (PHASE4)
Clinical Trial for 'Shen Qu Xiao Shi' Oral Liquid in the Treatments of Children's Functional Dyspepsia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Shenqu Xiaoshi oral liquid CI brief — competitive landscape report
Shenqu Xiaoshi oral liquid updates RSS · CI watch RSS
Ruijin Hospital portfolio CI